Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Deloitte
Julphar
McKesson
Express Scripts
Teva
Fish and Richardson
Colorcon
AstraZeneca

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,859,551

« Back to Dashboard

Which drugs does patent 8,859,551 protect, and when does it expire?

Patent 8,859,551 protects MIRVASO and is included in one NDA.

This patent has sixty-three patent family members in twenty-four countries.
Summary for Patent: 8,859,551
Title:Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
Abstract: In methods, compounds, and topical formulations for treatment of inflammatory skin disorders incorporating compounds represented by the formulas below: ##STR00001## wherein each of R.sub.1, R.sub.2, and R.sub.3 is independently hydrogen, hologen, alkyl, or alkoxy; each of R.sub.4 and R.sub.5 is independently hydrogen, alkyl, or alkoxy; and each of R.sub.6 and R.sub.7 is independently hydrogen, nitro, alkyl, or alkoxy; wherein each of A.sub.1, A.sub.3, and A.sub.4 is independently hydrogen or alkyl; and A.sub.2 is independently hydrogen or hydroxy; and wherein each of B.sub.1, B.sub.2, and B.sub.3 is independently hydrogen, hydroxy, or alkoxy; and each of B.sub.4 and B.sub.5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat inflammatory skin disorders and the symptoms associated therewith.
Inventor(s): DeJovin; Jack A. (New Brunswick, NJ), DeJovin; Isabelle Jean (New Brunswick, NJ)
Assignee: Galderma Laboratories Inc. (Fort Worth, TX)
Application Number:13/775,784
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 8,859,551

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs Lp MIRVASO brimonidine tartrate GEL;TOPICAL 204708-001 Aug 23, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TOPICAL TREATMENT OF FACIAL ERYTHEMA OF ROSACEA ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,859,551

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,439,241 Compounds, formulations, and methods for treating or preventing rosacea ➤ Try a Free Trial
8,410,102 Methods and compositions for treating or preventing erythema ➤ Try a Free Trial
8,586,586 Methods and compositions for treating or preventing erythema ➤ Try a Free Trial
8,426,410 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders ➤ Try a Free Trial
8,513,249 Methods and compositions for safe and effective treatment of erythema ➤ Try a Free Trial
8,993,571 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders ➤ Try a Free Trial
8,557,817 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders ➤ Try a Free Trial
8,513,247 Methods and compositions for safe and effective treatment of erythema ➤ Try a Free Trial
7,838,563 Compounds, formulations, and methods for ameliorating telangiectasias ➤ Try a Free Trial
8,231,885 Compounds, formulations, and methods for ameliorating telangiectasis ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,859,551

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 530185 ➤ Try a Free Trial
Australia 2004242967 ➤ Try a Free Trial
Australia 2005247467 ➤ Try a Free Trial
Australia 2011231543 ➤ Try a Free Trial
Brazil PI0511519 ➤ Try a Free Trial
Canada 2530938 ➤ Try a Free Trial
Canada 2567401 ➤ Try a Free Trial
Canada 2792646 ➤ Try a Free Trial
Canada 2824612 ➤ Try a Free Trial
China 101380321 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
McKinsey
Fuji
Colorcon
Citi
Boehringer Ingelheim
Federal Trade Commission
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot